Fund moves

Danaher Corporation (DHR): Davis R M Inc reduced its stake -3,707 shares

Davis R M Inc reduced its stake in Danaher Corporation, per its Q2 2026 13F.

306K
Shares reported · -3,707 vs prior quarter
0.92%
Disclosed portfolio weight
$58.5M
Reported value
Holdings as of
Jun 30, 2026
Filed
Aug 14, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 27, 2026CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
  2. Jul 21, 2026Company filing · Form 8-K · ResultsReported its results
  3. Jul 31, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors (and 1 more item)“On August 3, 2026, Danaher Corporation (the “Company” or “Danaher”) announced that, effective as of October 1, 2026 (the “Effective Date”), the Board of Directors of the Company (the “Board”) has appointed Julie Sawyer Montgomery as President and Chief Executive Officer of the Company (the “CEO”).”
  4. Aug 7, 2026FDAFDA device clearance: Xpert Hemorrhagic Fever
  5. Aug 7, 2026FDAFDA device clearance: Aperio iQC DX Software
  6. Aug 7, 2026FDAFDA device clearance: Aperio GT 450 DX; Aperio GT 180 DX
  7. Aug 12, 2026FDARecall: DxU 840m Iris, REF: C76947; DxU 850m Iris, REF: C49513
  8. Aug 12, 2026FDARecall: IQ200 SPRINT, REF: 700-3322,700-3322RFB, 700-3325, 700-3326, B48997; IQ200 SELECT, REF: 700-3340, 700-3345, 700-3347, B48998, C10684; IQ200 ELITE, REF: 700-337…

What came next

  1. Aug 18, 2026FDARecall: The ABL90 FLEX and ABL90 FLEX PLUS analyzers are intended for use by trained technologists, nurses, physicians and therapists. It is intended for use in a labo…
  2. Aug 21, 2026Insider · 1 personInsiders: 3 sales (~$12.7M)
  3. Aug 31, 2026CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  4. Sep 2, 2026FDARecall: DxC 500 AU Clinical Chemistry Analyzers: 1. AU w/out ISE, Part No. C63519 2. AU w/ISE, Part No. C63520
  5. Sep 2, 2026FDARecall: DxC 500i Clinical Analyzer Modules: 1. DxC 500 AU Module w/ISE, DxC 500i, Part No. C63522 2. DxC 500 AU Module, DxC 500i, Part No. C63521 3. Access 2 Module, D…
  6. Sep 2, 2026CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
  7. Sep 21, 2026FDAFDA device clearance: Access NT-proBNP
  8. Sep 21, 2026FDARecall: ROTOR ASSY-SW41, Reference Number 331362, when the rotors are installed in the following centrifuges: Optima XPN-100 (Model Numbers A99846 and A94469), Optima…
  9. Sep 21, 2026FDARecall: ROTOR ASSY-SW40, Reference Number 331302, when the rotors are installed in the following centrifuges: Optima XPN-100 (Model Numbers A99846 and A94469), Optima…
  10. Sep 25, 2026FDAFDA device clearance: Xpert Respiratory Panel
  11. Oct 9, 2026Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On October 9, 2026, the Board of Directors (the “Board”) of Danaher Corporation (the “Company” or “Danaher”) increased the size of the Board to thirteen members and appointed Daniel L. Comas and Robert M. Hershberg to the Board, in each case effective immediately.”
  12. Oct 19, 2026FDAFDA device clearance: Access MeMed BV
  13. Oct 20, 2026FDAFDA device clearance: Access BNP II
  14. Oct 21, 2026Company filing · Form 8-K · ResultsReported its results
  15. Oct 28, 2026Insider · 2 peopleInsiders: 4 sales (~$8.8M)
  16. Oct 30, 2026FDAFDA device clearance: Xpert® Hemorrhagic Fever Panel
  17. Nov 5, 20265% stakeFMR LLC reported a passive stake (13G) of 5.6%
  18. Nov 9, 2026Insider · 2 peopleInsiders: 2 sales (~$4.6M)
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Danaher Corporation

For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 7 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.

How this filing works

Explore the data

Common questions

What does this filing report about Danaher Corporation (DHR) stock?

Davis R M Inc reduced its stake in Danaher Corporation, per its Q2 2026 13F. Now 306K shares, $58.5M reported value, 0.92% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Jun 30, 2026. Filed: Aug 14, 2026.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Danaher Corporation recently?

For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 7 fund holdings reports (13F) dated in the last 90 days. They are listed on the DHR page.

Does this mean DHR stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Danaher Corporation

Everything OQRO holds on this company is on its DHR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data